Cancer cells grow and divide in an uncontrolled manner. A new study now shows how alterations in a cell's degradation hubs, called lysosomes, can cause abnormal cell growth. The results are published in the scientific journal Nature Communications.
Normal cells have several control mechanisms that prevent them from growing uncontrollably. During the last few years, it has become increasingly clear that these regulatory processes are taking place on the surface of lysosomes, which are small membrane-encapsulated vesicles that function as degradation centres of all cells. A cell can have hundreds of lysosomes that are organised into complex networks. Cancer cells frequently have alterations in the organisation of their lysosome networks, although it remains unclear to what degree this contributes to tumor progression.
In the present study, scientists, have found that the amount of lysosomes in a lysosomal network affects cellular growth through the activation of a protein called mTOR.
"We saw that when the number of lysosomes increased, mTOR molecules on the lysosomal surface became hyperactivated. Since mTOR is a central stimulator of cellular growth, this leads to increased growth, says the study lead.
The scientists have also identified another protein, Rap1, that regulates both the number of lysosomes present in the lysosomal network, and its organization.
When amino acids are limited, the Rap1-GTPases confine lysosomes to the perinuclear region and reduce lysosome abundance, which suppresses mTORC1 signaling. Rap1 activation, which is independent of known amino acid signaling factors, limits the lysosomal surface available for mTORC1 activation. Conversely, Rap1 depletion expands the lysosome population, which markedly increases association between mTORC1 and its lysosome-borne activators, leading to mTORC1 hyperactivity.
"Although this study is in an early phase, it demonstrates that lysosomes play a central role in cellular growth control. We need more knowledge about how changes in a lysosomal network contribute to cancer, which is something we are about to test in models of human cancers," says the author.
https://www.uu.se/en/news-media/news/article/?id=14266&typ=artikel&lang=en
https://www.nature.com/articles/s41467-020-15156-5
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Frap1-gtpases-control&filter=22
Lysosomal alterations can lead to cancer
- 2,041 views
- Added
Edited
Latest News
Complete vascularization of…
By newseditor
Posted 28 Mar
Immune cells identified as…
By newseditor
Posted 28 Mar
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Other Top Stories
Classification scheme developed for newly identified multiple scler…
Read more
Modular complement assemblies for mitigating inflammatory conditions
Read more
Axonal transport impaired by the loss of methylation of huntingtin
Read more
Microglia use TAM receptors to detect and engulf amyloid β plaques
Read more
Dietary supplement to restore cytoskeleton and transportation netwo…
Read more
Protocols
Spatial proteomics in neuro…
By newseditor
Posted 28 Mar
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Publications
A microfluidic platform int…
By newseditor
Posted 28 Mar
Salmonella manipulates macr…
By newseditor
Posted 28 Mar
BHLHE40/41 regulate microgl…
By newseditor
Posted 28 Mar
Balancing neuronal activity…
By newseditor
Posted 28 Mar
OSBP-mediated PI(4)P-choles…
By newseditor
Posted 28 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar